Literature DB >> 18259757

[Descemet's stripping with automated endothelial keratoplasty (DSAEK)].

C Cursiefen1, F E Kruse.   

Abstract

BACKGROUND: Although penetrating keratoplasty remains the gold standard for surgically treating corneal endothelial pathologies, tremendous progress has been made in recent years to improve the technology of (posterior) lamellar keratoplasty.
METHODS: Literature review from PubMed and own data.
RESULTS: Posterior lamellar keratoplasty using a microkeratome (Descemet's stripping with automated endothelial keratoplasty, or DSAEK) is a reliable surgical technique for Fuchs' endothelial dystrophy and pseudophakic bullous keratopathy. Visual rehabilitation is faster with lamellar keratoplasty than penetrating keratoplasty.
CONCLUSION: Posterior lamellar keratoplasty techniques such as DSAEK will become an important surgical treatment option for corneal endothelial pathologies.

Entities:  

Mesh:

Year:  2008        PMID: 18259757     DOI: 10.1007/s00347-007-1680-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  33 in total

1.  Sutureless, posterior lamellar keratoplasty: a case report of a modified technique.

Authors:  Gerrit R J Melles; Frank Lander; Carla Nieuwendaal
Journal:  Cornea       Date:  2002-04       Impact factor: 2.651

2.  Cataract progression and treatment following posterior lamellar keratoplasty.

Authors:  Marianne O Price; Francis W Price
Journal:  J Cataract Refract Surg       Date:  2004-06       Impact factor: 3.351

Review 3.  Immune privilege and angiogenic privilege of the cornea.

Authors:  Claus Cursiefen
Journal:  Chem Immunol Allergy       Date:  2007

Review 4.  [Current treatment for dry eye syndrome].

Authors:  C Cursiefen; C Jacobi; T Dietrich; F E Kruse
Journal:  Ophthalmologe       Date:  2006-01       Impact factor: 1.059

5.  Deep lamellar endothelial keratoplasty visual acuity, astigmatism, and endothelial survival in a large prospective series.

Authors:  Mark A Terry; Paula J Ousley
Journal:  Ophthalmology       Date:  2005-09       Impact factor: 12.079

6.  Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty.

Authors:  C Cursiefen; H Wenkel; P Martus; A Langenbucher; N X Nguyen; B Seitz; M Küchle; G O Naumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-07       Impact factor: 3.117

7.  New triple procedure: Descemet's stripping and automated endothelial keratoplasty combined with phacoemulsification and intraocular lens implantation.

Authors:  Douglas J Covert; Steven B Koenig
Journal:  Ophthalmology       Date:  2007-04-12       Impact factor: 12.079

8.  Descemet membrane endothelial keratoplasty (DMEK).

Authors:  Gerrit R J Melles; T San Ong; Bob Ververs; Jacqueline van der Wees
Journal:  Cornea       Date:  2006-09       Impact factor: 2.651

9.  Assessment of eye bank-prepared posterior lamellar corneal tissue for endothelial keratoplasty.

Authors:  Linda Rose; César A Briceño; Walter J Stark; Dante G Gloria; Albert S Jun
Journal:  Ophthalmology       Date:  2007-06-28       Impact factor: 12.079

10.  [Clinical aspects and treatment of immune reactions following penetrating normal-risk keratoplasty].

Authors:  N X Nguyen; B Seitz; A Langenbucher; H Wenkel; C Cursiefen
Journal:  Klin Monbl Augenheilkd       Date:  2004-06       Impact factor: 0.700

View more
  3 in total

1.  [Influence of corneal thickness on intraocular pressure measurements following Descemet's stripping automated endothelial keratoplasty (DSAEK)].

Authors:  M K J Klamann; A-K B Maier; J Gonnermann; N Torun; P C Ruokonen
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

Review 2.  Descemet stripping endothelial keratoplasty--rapid recovery of visual acuity.

Authors:  Philip Maier; Thomas Reinhard; Claus Cursiefen
Journal:  Dtsch Arztebl Int       Date:  2013-05-24       Impact factor: 5.594

Review 3.  [Descemet's stripping automated endothelial keratoplasty (DSAEK)].

Authors:  C Cursiefen; F E Kruse
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.